Synthesis and structure-activity relationships for some novel diflapolin derivatives with benzimidazole subunit.
Lisa VieiderEva ZoellerErik RompMartin SchoenthalerVictor Hernández-OlmosVeronika TemmlThomas HasenoehrlDaniela SchusterOliver WerzUlrike GarschaBarbara MatuszczakPublished in: Journal of enzyme inhibition and medicinal chemistry (2022)
A series of derivatives of the potent dual soluble epoxide hydrolase (sEH)/5-lipoxygenase-activating protein (FLAP) inhibitor diflapolin was designed, synthesised, and characterised. These novel compounds, which contain a benzimidazole subunit were evaluated for their inhibitory activity against sEH and FLAP. Molecular modelling tools were applied to analyse structure-activity relationships (SAR) on both targets and to predict solubility and gastrointestinal (GI) absorption. The most promising dual inhibitors of these series are 5a , 6b, and 6c .